Skip to main content

Table 1 In vitro antimycobacterial activity of Ursolic acid (UA) and Oleanolic acid (OA) tested by MABA assay

From: Ursolic and oleanolic acids as antimicrobial and immunomodulatory compounds for tuberculosis treatment

M. tuberculosis strain

MIC (μg mL-1)

(ATCC)

UA

OA

UA/OA

H37Rv (27294)

25

50

12.5

INH-R (35822)

25

25

25

RIF-R (35838)

25

25

25

EMB-R (35837)

25

25

25

STR-R (35820)

12.5

50

25

DR clinical isolates

MMDO

25

50

ND

MTY147

25

50

ND

Non-tuberculous mycobacterium

M. chelonae

100

100

100

M. avium

100

100

100

M. smegmatis

>200

100

100

M. fortuitum

100

100

100

M. simiae

>200

100

100

  1. H37Rv: sensitive strain to INH, RIF, EMB, STR, and pyrazinamide; RIF-R: rifampicin-resistant to H37Rv; STR-R: streptomycin-resistant to H37RV; INH-R: isoniazid-resistant to H37Rv and EMB-R: ethambutol-resistant to H37Rv; MMDO: strain resistant to isoniazid and ethambutol; MTY 147: strain resistant to isoniazid, rifampicin, ethambutol and ethionamide. MIC: minimum inhibitory concentration. Data are means of three determinations. UA: ursolic acid; OA: oleanolic acid; UA/OA: mixture of ursolic and oleanolic acids.